ALLISON DYE: Open Payments
NPI 1992122667 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 20 payments from 13 companies in 2025. Trend: 2023 $415 · 2024 $520 · 2025 $507
Food & beverage: $488Education: $19
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $120 |
| Amgen Inc. | 4 | $66 |
| Medtronic, Inc. | 1 | $59 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| PFIZER INC. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: Veozah, SYMPLICITY G3, TRELEGY ELLIPTA, INSPIRE, EVENITY, TZIELD, JARDIANCE, REPATHA.
Industry payments across AL — which companies pay providers there.
